Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial - Maher, Toby M.; Corte, Tamera J; Fischer, Aryeh; Kreuter, Michael; Lederer, David J; Molina-Molina, Maria; Axmann, Judit; Kirchgaessler, Klaus-Uwe; Samara, Katerina; Gilberg, Frank; Cottin, Vincent (The lancet. Respiratory medicine, 2020)
Gesehen am 26.03.2020